Nurix Therapeutics management to participate in September investor conferences
Nurix Therapeutics said company management will participate in upcoming September investor conferences.
BRISBANE, Calif., Sept.
01, 2026 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc.
NASDAQ:NRIX, a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of targeted protein degradation medicines, today announced that Company management will participate in fi…